Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Pfizer Healthcare Ireland regarding Xalkori (crizotinib): vision disorders, including risk of severe visual loss, need for monitoring in paediatric patients
Important Safety Information – Xalkori (crizotinib)